Pune, India -- (SBWIRE) -- 06/29/2018 -- The Intra-Nasal route of drug administration is becoming popular due to its noninvasive nature thereby reducing pain and threat of infections and allows the patient to self-administer drugs without any help from anyone. Moreover recent research has also pointed its applications related to drug delivery to the brain. The Middle East and Africa Nasal Drug Delivery Market to reach around $ 1.59 billion in 2022 growing at a CAGR of 8.1%; this market was worth $ 1 billion in 2015.

The nasal route administration is experiencing tremendous growth due to its noninvasive nature consequently reducing pain and threat of infections. It allows the patient to self-administer drugs thus not requiring any external help. The high vasculature, high permeability, and low enzymatic environment of nasal cavity are perfectly apt for systemic delivery of drug molecules via nose. There is no risk of drug destruction by hydrogen chloride (HCl) present in the stomach thereby increasing bioavailability which reduces the dosage of the drug. This, in turn, leads to proportional reduction in side effects.

Increasing popularity of over-the-counter nasal drugs such as inhalers for the common cold is also propel the market in an upward manner. Nasal drugs prove to be advantageous for the market, with a plethora of factors like good penetration of the drugs into the nasal cavity, improving patient compliance, rapid absorption, onset of action, and requirement of low dosage.

Middle East and Africa Nasal Drug Delivery Market - Industry Developments

In May 2018, Merck Pty Ltd., South Africa, has been donating a number of vaccines to rural regions to assist the population that are considered susceptible to contracting Ebola in the Democratic Republic of Congo. Merck bought the rights to the vaccines in 2014 and since then have been actively contributing to this aspect. The rVSV-ZEBOV Ebola vaccine has been deployed to the Democratic Republic of Congo for mass vaccination and to curb the outbreak of Ebola.

Aspen Pharmacare (APN), South Africa, has officially opened its USD 75 million Port Elizabeth-based high containment facility, providing Aspen with the opportunity to advance exports with products used for rare indications. This move can cement Aspen's position as the top pharmaceutical manufacturer in the region.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2696 .

Middle East and Africa Nasal Drug Delivery Market - Key Players

Some of the key players in this market are

Novartis AG
Pfizer, Inc.
Sanofi-Aventis
Merck & Co., Inc.
AptarGroup Inc.
Johnson & Johnson Services Inc.
GlaxoSmithKline plc.
Becton Dickson

Middle East and Africa Nasal Drug Delivery Market - Drivers and Restraints

The market for nasal drug delivery is growing remarkably with a consistently good CAGR due to the benefits accompanying nasal drugs. Other driving factors include innovation of drugs which are absorbed easily from the nasal route, innovations in advanced products which allow the delivery of precise doses and also ease of administration. However, the restraints that threaten the growth of the market are irritation of the nasal route and the low dose of the drug that can be delivered as compared to other routes of administration. Other constraints include concurrent low popularity of the route which reduces economies of scale in producing these delivery devices and low awareness. According to an extensive report by Market Research Future (MRFR), the Middle East and Africa nasal drug delivery market is presumed to reach around USD 1.59 billion in 2022 surging at a CAGR of 8.1% from 2017 to 2022. The market was estimated to be worth USD 1 billion in 2015.

Middle East and Africa Nasal Drug Delivery Market - Segments

Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system, market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.

Middle East and Africa Nasal Drug Delivery Market - Regional Analysis

UAE is the largest market for nasal drug delivery in entire Middle East and Africa nasal drug delivery Market closely followed by Egypt. The rest of Africa's market is growing at a very fast rate due to huge unmet medical needs and growing popularity of nasal route.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/2696 .

Major Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

List of Tables

Table 1 Middle East and Africa Nasal Drug Delivery Market, 2013-2022 (USD Million)

Table 2 Middle East And Africa Nasal Drug Delivery Market, By Dosage Form, 2013-2022 (USD Million)

Table 3 Middle East And Africa Nasal Drug Delivery Market, By System, 2013-2022 (USD Million)

List of Figures

Figure 1 Research Process

Figure 2 Porters Five Forces Model

Figure 3 Middle East And Africa Nasal Drug Delivery Market, By Dosage Form

Continued….

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.